These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 13295486)

  • 21. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
    Schreiber RD; Götze O; Müller-Eberhard HJ
    J Exp Med; 1976 Oct; 144(4):1062-75. PubMed ID: 62010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
    Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
    J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
    [No Abstract]   [Full Text] [Related]  

  • 23. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

  • 24. Research on the properdin system. I. Inactivation of the third complement component through zymosan on inulin.
    HEISE ER
    Klin Wochenschr; 1958 Jan; 36(2):88-9. PubMed ID: 13540126
    [No Abstract]   [Full Text] [Related]  

  • 25. [The properdin system].
    WENSINCK F
    Pharm Weekbl; 1956 Oct; 91(20):737-44. PubMed ID: 13378963
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.
    Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J
    J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preparation of a bacteriocidic serum protein (properdin)].
    ISLIKER H; LINDER E
    Helv Physiol Pharmacol Acta; 1956; 14(2):C34-C35. PubMed ID: 13345236
    [No Abstract]   [Full Text] [Related]  

  • 28. [Properdin and natural immunity].
    DE LA GARZA BRITO A
    Rev Sanid Milit; 1955; 8(7-9):200-1. PubMed ID: 13298269
    [No Abstract]   [Full Text] [Related]  

  • 29. A simple method for isolation of human properdin by affinity chromatography.
    Konno T; Hirai H
    J Immunol Methods; 1976; 12(1-2):47-55. PubMed ID: 792350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.
    Nicholson A; Brade V; Lee GD; Shin HS; Mayer MM
    J Immunol; 1974 Mar; 112(3):1115-23. PubMed ID: 4811964
    [No Abstract]   [Full Text] [Related]  

  • 31. [Properdin, a serum factor of importance for natural resistance].
    BRO-RASMUSSEN F; KILLMANN SA
    Nord Med; 1956 Oct; 56(41):1479-82. PubMed ID: 13388106
    [No Abstract]   [Full Text] [Related]  

  • 32. [Properdin, serological factor of natural immunity].
    FAYE CM
    Gaz Med Fr; 1956 Apr; 63(8):771-2. PubMed ID: 13318329
    [No Abstract]   [Full Text] [Related]  

  • 33. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.
    PILLEMER L; SCHOENBERG MD; BLUM L; WURZ L
    Science; 1955 Sep; 122(3169):545-9. PubMed ID: 13255887
    [No Abstract]   [Full Text] [Related]  

  • 34. [Properdin].
    FERRARI F
    Boll Chim Farm; 1956 Jun; 95(6):258-66. PubMed ID: 13342173
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fibrinolysis and factors of aspecific immunity. Preliminary note].
    Ferrauto A; Giuffrida G; Terranova R
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1488-91. PubMed ID: 5878160
    [No Abstract]   [Full Text] [Related]  

  • 36. An alternative mechanism for the properdin system.
    NELSON RA
    J Exp Med; 1958 Oct; 108(4):515-35. PubMed ID: 13575682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
    BLUM L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
    [No Abstract]   [Full Text] [Related]  

  • 38. [Properdin and its immunological importance; present status of the question].
    DELAUNAY A; HENON M; BAZIN S; PELLETIER M
    Presse Med (1893); 1956 Jan; 64(4):65-7. PubMed ID: 13289716
    [No Abstract]   [Full Text] [Related]  

  • 39. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
    HINZ CF; WEDGWOOD RJ; PILLEMER L
    J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
    [No Abstract]   [Full Text] [Related]  

  • 40. The action of properdin on Toxoplasma gondii; a preliminary report.
    GRONROOS P
    Ann Med Exp Biol Fenn; 1955; 33(3):310-5. PubMed ID: 13259240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.